ANVISA RDC 660 &
Legal Import to Brazil

Everything Brazilian patients need to know about importing Medicanna USA products legally, including ANVISA authorization, Remessa Conforme, and prescription requirements.

100% Legal
Fully compliant with ANVISA RDC 660 since 2021.
Patient Portal
FDA Disclaimer (United States)

These statements have not been evaluated by the Food and Drug Administration (FDA). Medicanna USA products are not intended to diagnose, treat, cure, or prevent any disease. Hemp-derived CBD products containing less than 0.3% THC are legal under the 2018 US Farm Bill. Always consult a qualified healthcare provider before beginning any cannabinoid supplement.

What is ANVISA RDC 660?

ANVISA Resolution RDC No. 660 (published March 30, 2022) is the current Brazilian regulation that establishes the criteria for individual import authorization of cannabis-based products for medical use.

Key Points
  • Authorization is for individual patient use, not resale
  • Must have prescription from a licensed Brazilian physician
  • Product must be eligible under ANVISA RDC 660 for individual patient import authorization
  • One authorization per product per 6-month period
  • Quantity limited to 6-month supply
Prescription Requirements
Licensed Brazilian physician (CRM registered)
Written prescription (in Portuguese)
Product name, concentration, and quantity specified
Diagnosis (CID-10 code)
Valid for 6 months from issue date
Original signature + CRM stamp

How to Import Legally — Step by Step

The complete process for Brazilian patients to legally import Medicanna USA products.

1

Consult a Cannabis-Friendly Physician

Find a physician trained in cannabinoid medicine who can evaluate your condition and issue an ANVISA-compliant prescription.

2

Obtain Your Prescription

Receive a written prescription specifying the product, concentration, quantity (up to 6-month supply), and your diagnosis (CID-10 code).

3

Apply for ANVISA Authorization

Submit your application through the official ANVISA Solicita system (gov.br). Required documents: prescription, patient ID, and product information. Processing: 15–45 business days.

4

Place Your Order with Medicanna USA

Once you have ANVISA authorization, place your order through our patient portal. Provide your authorization number, ANVISA file number, and shipping address.

5

Remessa Conforme Shipping

We ship via Remessa Conforme — Brazil's international e-commerce import program, launched in 2023. Tax treatment may vary depending on courier, documentation and customs review.

6

Receive Your Order

Your package arrives with full documentation: CoA, invoice, ANVISA authorization number, and Medicanna USA lot traceability.

What is Remessa Conforme?

Remessa Conforme is Brazil's compliant international e-commerce import program, established by the Federal Revenue Service (Receita Federal) in 2023. It replaced the informal "blusa de frio" grey-market imports with a transparent, taxed, and legally protected framework.

Faster customs clearance (typically 3–7 days)
Tax treatment may vary depending on courier, documentation and customs review
Legal protection — package cannot be seized if properly documented
Full tracking visibility in Correios/Courier system
Important Note

Tax treatment for Medicanna USA products may vary depending on courier, documentation and customs review by the Receita Federal. Confirm the current tax treatment with your importing courier or customs broker before purchase.

Documents We Provide
Certificate of Analysis (CoA) for every lot
Commercial invoice with HS code and full product description
ANVISA authorization reference number
Lot traceability QR code
Portuguese-language product documentation

Compliance FAQ

Yes - with ANVISA authorization under RDC 660. Without authorization, personal import of cannabis-derived products is not legally protected.

No. ANVISA RDC 660 requires a valid prescription from a licensed Brazilian physician. No prescription = no ANVISA authorization = customs seizure risk.

Typically 15-45 business days for complete applications. Incomplete submissions take longer.

If you have a valid ANVISA authorization, the package should be released. Medicanna USA provides all documentation required to facilitate customs clearance. Contact us immediately if this occurs.

ANVISA maintains a list of authorized cannabis-based products. We work to ensure our products meet the specifications required for individual import authorization. Contact us to confirm the current status of specific products.

ANVISA authorization under RDC 660 covers cannabis-derived products for personal medical use. The specific cannabinoid composition must be detailed in the prescription. Not all cannabinoids have the same regulatory status. Contact us for current product-specific compliance status.

Ready to Start Your Authorization?

Register as a patient, submit your documents, and we'll guide you through every step of the process.

Get Wellness Tips & Exclusive Offers

Join patients and wellness advocates who trust Medicanna USA for certified quality cannabinoids.

No spam. Unsubscribe anytime. We respect your privacy.